CG
Clarus Group’s Matinas BioPharma MTNB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-12,000
| Closed | -$1.9K | – | 120 |
|
2024
Q2 | $1.9K | Hold |
12,000
| – | – | ﹤0.01% | 115 |
|
2024
Q1 | $3.25K | Hold |
12,000
| – | – | ﹤0.01% | 107 |
|
2023
Q4 | $2.59K | Hold |
12,000
| – | – | ﹤0.01% | 102 |
|
2023
Q3 | $1.56K | Hold |
12,000
| – | – | ﹤0.01% | 110 |
|
2023
Q2 | $4.32K | Hold |
12,000
| – | – | ﹤0.01% | 113 |
|
2023
Q1 | $5.64K | Hold |
12,000
| – | – | 0.01% | 95 |
|
2022
Q4 | $6K | Hold |
12,000
| – | – | 0.01% | 92 |
|
2022
Q3 | $8K | Hold |
12,000
| – | – | 0.01% | 92 |
|
2022
Q2 | $9K | Hold |
12,000
| – | – | 0.01% | 103 |
|
2022
Q1 | $10K | Hold |
12,000
| – | – | 0.01% | 115 |
|
2021
Q4 | $13K | Hold |
12,000
| – | – | 0.01% | 108 |
|
2021
Q3 | $16K | Hold |
12,000
| – | – | 0.01% | 109 |
|
2021
Q2 | $9K | Hold |
12,000
| – | – | 0.01% | 110 |
|
2021
Q1 | $12K | Hold |
12,000
| – | – | 0.01% | 103 |
|
2020
Q4 | $17K | Buy |
+12,000
| New | +$17K | 0.01% | 99 |
|